会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 32. 发明授权
    • Low powered activation arrangement and method thereof
    • 低功率激活装置及其方法
    • US09553580B2
    • 2017-01-24
    • US13999599
    • 2014-03-11
    • Jack Chu
    • Jack Chu
    • H03K17/96A63H3/02A63H3/28H01H47/00
    • H03K17/96A63H3/02A63H3/28A63H2200/00Y10T307/766Y10T307/826
    • A fabric product includes a body having a skin made by interweaving a plurality of textile fabrics and a low powered activation arrangement which includes an electronic unit and one or more conductive threads extended underneath the skin of the body. The electronic unit includes a power source, an activation circuit which is a low powered activation circuit, and an operator. Each of the conductive threads has a proximal end portion electrically coupled with the activation circuit and a distal end portion which is extended to an outer surface of the skin of the body at a predetermined location thereof and is arranged in such a manner that when the distal end portion of the conductive thread is being contacted, the activation circuit is activated to actuate the operator.
    • 织物产品包括具有通过交织多个纺织织物制成的皮肤的主体和包括电子单元和延伸在身体的皮肤下方的一个或多个导电丝的低功率激活装置。 电子单元包括电源,作为低功率启动电路的启动电路和操作者。 每个导电线具有与激活电路电耦合的近端部分和远端部分,该远端部分在其预定位置处延伸到主体的皮肤的外表面,并且以这样的方式设置, 导电线的端部正在接触,启动电路被激活以致操作者。
    • 33. 发明申请
    • In Situ Blood Vessel and Aneurysm Treatment
    • 原位血管和动脉瘤治疗
    • US20140058356A1
    • 2014-02-27
    • US14068500
    • 2013-10-31
    • Jack ChuBrian Raze
    • Jack ChuBrian Raze
    • A61M5/00
    • A61M5/00A61L31/16
    • Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravascularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.
    • 用局部递送治疗剂治疗动脉瘤血管,从而降低或减轻动脉瘤的严重程度,并且在与排除装置的放置一起使用时,可以从放置期间发生的任何干扰提供更快速的血管恢复 的排除设备。 将治疗剂置于时间释放载体培养基的动脉瘤部位,使得治疗剂在一段时间内释放到动脉瘤部位,而不需要提供治疗剂的全身引入。 可以通过使用导管将载体例如通过使用腹腔镜或血管内引入患者真皮中。 载体可以是固体基质,粘稠液体或液体形式。
    • 35. 发明申请
    • SEARCH QUERY USER INTERFACE
    • 搜索查询用户界面
    • US20080256457A1
    • 2008-10-16
    • US12145079
    • 2008-06-24
    • Jack ChuChris ManciniLawrence Morrisroe
    • Jack ChuChris ManciniLawrence Morrisroe
    • G06F3/048
    • G06F17/30899G06F3/048G06F3/1438G06F5/10
    • In a client-server system where a client system presents a browser for user interaction, a browser user interface includes functionality for handling dynamic interface elements received by the browser in connection with received pages, presented as part of the browser user interface and modified in response to selected user input without requiring farther interaction with a server. In addition to, or in place of, dynamic interface elements such as slide sheets, the browser user interface might also include a rotation display area, tool displays that can overlay a page, opaquely or semi-transparently, menu structures, and an ability for the user to modify a page layout without requiring server interaction. The browser might comprise storage for a plurality of rotation display items for storing a summary and a primary presentation for each rotation display item, logic for displaying, by the browser, primary presentations for less all of the plurality of rotation display items in the rotation display area, logic for displaying, by the browser, summaries for items wherein the number of summaries is greater than the number of primary presentations presented at one time, logic for highlighting, among the summaries displayed, the ones of the summaries that correspond to the primary presentations displayed in the rotation display area; and logic for rotating the plurality of rotation display items to display primary presentations for a different subsets of the rotation display items and for updating highlighting of summaries to correspond to the different subsets of rotation display items.
    • 在客户机系统中,客户端系统呈现用于用户交互的浏览器,浏览器用户界面包括用于处理由浏览器接收的结合接收到的页面的动态接口元素的功能,作为浏览器用户界面的一部分呈现并被修改 到选定的用户输入,而不需要与服务器进一步的交互。 除了动画界面元素(例如幻灯片)之外,或者代替动画界面元素,浏览器用户界面还可以包括旋转显示区域,可以不透明地或半透明地覆盖页面的工具显示器,菜单结构以及能够 用户修改页面布局而不需要服务器交互。 浏览器可以包括用于存储用于每个旋转显示项目的摘要和主要呈现的多个旋转显示项目的存储,用于由浏览器显示用于旋转显示中较少所有多个旋转显示项目的主要呈现的逻辑 区域,用于由浏览器显示其中总结数量大于一次呈现的主要呈现数量的项目的摘要,在显示的摘要中突出显示的逻辑是与主要对象相对应的摘要 演示文稿显示在旋转显示区域; 以及用于旋转多个旋转显示项目以显示用于旋转显示项目的不同子集的主要呈现以及用于更新与不同的旋转显示项目子集对应的摘要的突出显示的逻辑。
    • 36. 发明授权
    • In situ blood vessel and aneurysm treatment
    • 原位血管和动脉瘤治疗
    • US07396540B2
    • 2008-07-08
    • US10424005
    • 2003-04-25
    • Jack ChuBrian Raze
    • Jack ChuBrian Raze
    • A61F2/00A61F2/06A61M29/00
    • A61M5/00A61L31/16
    • Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravacularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.
    • 用局部递送治疗剂治疗动脉瘤血管,从而降低或减轻动脉瘤的严重程度,并且在与排除装置的放置一起使用时,可以从放置期间发生的任何干扰提供更快速的血管恢复 的排除设备。 将治疗剂置于时间释放载体培养基的动脉瘤部位,使得治疗剂在一段时间内释放到动脉瘤部位,而不需要提供治疗剂的全身引入。 载体可以通过患者的真皮引入,例如通过使用腹腔镜或通过使用导管在脑内引入。 载体可以是固体基质,粘稠液体或液体形式。